← All Sponsors
SPONSOR

Academic and Community Cancer Research United

Total Trials
1
Recruiting
1
Phases
Phase 2
Conditions studied: Recurrent Mantle Cell LymphomaRefractory Mantle Cell Lymphoma
NCT05910801 Phase 2
Recruiting

Tafasitamab, Lenalidomide and Venetoclax for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma

Recurrent Mantle Cell Lymphoma
United States View Trial →